Systemic Immune-Inflammation Index Is a Prognostic Predictor in Patients with Intrahepatic Cholangiocarcinoma Undergoing Liver Transplantation

Table 1

Baseline characteristics in iCCA patients.

Characteristic	Values
Gender
Male	25 (89.3)
Female	3 (10.7)
Age (years)	51.5 (46.8-60.0)
Child-Pugh Class
A	7 (25.0)
B	13 (46.4)
C	8 (28.6)
BMI	23.2 (20.4-23.9)
MELD score	11.0 (7.8-16.5)
CEA (μg/L)	3.2 (2.5-8.6)
CA19-9 (U/L)	125.9 (28.1-1436.6)
AFP (ng/L)	4.2 (2.6-5.1)
Tumor number
Single	19 (67.9)
Multiple	9 (32.1)
Largest tumor size (cm)	5.8 (2.4-7.5)
HBsAg
Positive	17 (60.7)
Negative	11 (39.3)
Pretransplant locoregional therapy	21 (75.0)
Differentiation
Well	2 (7.1)
Moderate	18 (64.3)
Poor	8 (28.6)
Vascular invasion	9 (32.1)
Tumor recurrence	15 (53.6)
SII	447.5 (289.9-930.7)
PLR	125.8 (98.6-184.1)
NLR	2.9 (1.8-4.1)
Follow-up (months)	33.5 (18.8-50.8)

Data are presented as (%) or median (IQR).